Maninder Hora, SVP Pharma Development & Mfg Operations at NEKTAR THERAPEUTICS (NKTR), sold 180,000 shares at $21.70 ($3.9M) on 2017-04-05, disclosed to the SEC on 2017-04-07.
Open-market sale of $3.9M NKTR by SVP Pharma Development & Mfg Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2018-11-19 | $359K | — | Filing → |
| NKTR | SELL | 2018-05-18 | $677K | — | Filing → |
| NKTR | SELL | 2018-04-12 | $106K | — | Filing → |